These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 16110930)

  • 1. Diabetes-related symptoms and negative mood in participants of a targeted population-screening program for type 2 diabetes: The Hoorn Screening Study.
    Adriaanse MC; Dekker JM; Spijkerman AM; Twisk JW; Nijpels G; van der Ploeg HM; Heine RJ; Snoek FJ
    Qual Life Res; 2005 Aug; 14(6):1501-9. PubMed ID: 16110930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. No substantial psychological impact of the diagnosis of Type 2 diabetes following targeted population screening: The Hoorn Screening Study.
    Adriaanse MC; Snoek FJ; Dekker JM; Spijkerman AM; Nijpels G; Twisk JW; van der Ploeg HM; Heine RJ
    Diabet Med; 2004 Sep; 21(9):992-8. PubMed ID: 15317604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Health-related quality of life in the first year following diagnosis of Type 2 diabetes: newly diagnosed patients in general practice compared with screening-detected patients. The Hoorn Screening Study.
    Adriaanse MC; Dekker JM; Spijkerman AM; Twisk JW; Nijpels G; van der Ploeg HM; Heine RJ; Snoek FJ
    Diabet Med; 2004 Oct; 21(10):1075-81. PubMed ID: 15384953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quality of life in type 2 diabetic patients is affected by complications but not by intensive policies to improve blood glucose or blood pressure control (UKPDS 37). U.K. Prospective Diabetes Study Group.
    Diabetes Care; 1999 Jul; 22(7):1125-36. PubMed ID: 10388978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diabetic patients detected by population-based stepwise screening already have a diabetic cardiovascular risk profile.
    Spijkerman AM; Adriaanse MC; Dekker JM; Nijpels G; Stehouwer CD; Bouter LM; Heine RJ
    Diabetes Care; 2002 Oct; 25(10):1784-9. PubMed ID: 12351478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Motivational profiles, accelerometer-derived physical activity, and acute diabetes-related symptoms in adults with type 2 diabetes.
    Castonguay A; Miquelon P
    BMC Public Health; 2018 Apr; 18(1):469. PubMed ID: 29636035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Symptoms and well-being in relation to glycemic control in type II diabetes.
    Van der Does FE; De Neeling JN; Snoek FJ; Kostense PJ; Grootenhuis PA; Bouter LM; Heine RJ
    Diabetes Care; 1996 Mar; 19(3):204-10. PubMed ID: 8742562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relationship of depressive symptoms to symptom reporting, self-care and glucose control in diabetes.
    Ciechanowski PS; Katon WJ; Russo JE; Hirsch IB
    Gen Hosp Psychiatry; 2003; 25(4):246-52. PubMed ID: 12850656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The 12-item well-being questionnaire. An evaluation of its validity and reliability in Dutch people with diabetes.
    Pouwer F; van der Ploeg HM; Adèr HJ; Heine RJ; Snoek FJ
    Diabetes Care; 1999 Dec; 22(12):2004-10. PubMed ID: 10587834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perceptions of risk in adults with a low or high risk profile of developing type 2 diabetes; a cross-sectional population-based study.
    Adriaanse MC; Twisk JW; Dekker JM; Spijkerman AM; Nijpels G; Heine RJ; Snoek FJ
    Patient Educ Couns; 2008 Nov; 73(2):307-12. PubMed ID: 18718733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Performance of an NIDDM screening questionnaire based on symptoms and risk factors.
    Ruige JB; de Neeling JN; Kostense PJ; Bouter LM; Heine RJ
    Diabetes Care; 1997 Apr; 20(4):491-6. PubMed ID: 9096967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Symptom burden of adults with type 2 diabetes across the disease course: diabetes & aging study.
    Sudore RL; Karter AJ; Huang ES; Moffet HH; Laiteerapong N; Schenker Y; Adams A; Whitmer RA; Liu JY; Miao Y; John PM; Schillinger D
    J Gen Intern Med; 2012 Dec; 27(12):1674-81. PubMed ID: 22854982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of macrovascular disease amongst type 2 diabetic patients detected by targeted screening and patients newly diagnosed in general practice: the Hoorn Screening Study.
    Spijkerman AM; Henry RM; Dekker JM; Nijpels G; Kostense PJ; Kors JA; Ruwaard D; Stehouwer CD; Bouter LM; Heine RJ
    J Intern Med; 2004 Nov; 256(5):429-36. PubMed ID: 15485479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diabetes-related symptom distress in association with glucose metabolism and comorbidity: the Hoorn Study.
    Adriaanse MC; Pouwer F; Dekker JM; Nijpels G; Stehouwer CD; Heine RJ; Snoek FJ
    Diabetes Care; 2008 Dec; 31(12):2268-70. PubMed ID: 18728236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening for Type 2 diabetes: an exploration of subjects' perceptions regarding diagnosis and procedure.
    Adriaanse M; Snoek F; Dekker J; van der Ploeg H; Heine R
    Diabet Med; 2002 May; 19(5):406-11. PubMed ID: 12027929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Negative mood and quality of life in patients with asthma.
    Ekici A; Ekici M; Kara T; Keles H; Kocyigit P
    Qual Life Res; 2006 Feb; 15(1):49-56. PubMed ID: 16411030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The psychological impact of screening for type 2 diabetes.
    Adriaanse MC; Snoek FJ
    Diabetes Metab Res Rev; 2006; 22(1):20-5. PubMed ID: 16142814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of screening for Type 2 diabetes in siblings of patients with established diabetes.
    Farmer AJ; Doll H; Levy JC; Salkovskis PM
    Diabet Med; 2003 Dec; 20(12):996-1004. PubMed ID: 14632700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. No negative effects of a multi-factorial, intensified treatment on self-reported health status, treatment satisfaction, and diabetes-related distress in screen-detected type 2 diabetes patients. The ADDITION-Netherlands study.
    van den Donk M; Gorter KJ; Rutten GE
    Qual Life Res; 2010 May; 19(4):509-13. PubMed ID: 20155327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adding insulin glargine versus rosiglitazone: health-related quality-of-life impact in type 2 diabetes.
    Vinik AI; Zhang Q
    Diabetes Care; 2007 Apr; 30(4):795-800. PubMed ID: 17259481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.